Quantitation of Minimal Residual Disease in Patients with Chronic Lymphocytic Leukemia Using Locked Nucleic Acid-Modified, Fluorescently Labeled Hybridization Probes and Real-Time PCR Technology

Author: Peková Soňa  

Publisher: Adis International

ISSN: 1177-1062

Source: Molecular Diagnosis & Therapy, Vol.11, Iss.5, 2007-01, pp. : 325-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract